Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of E-coxia 120 vs ARCOXIA 120 mg in healthy Thai volunteers (fasting, single-dose crossover)
TCTR20240628003Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etoricoxib in pain and Inflammatory Disorders (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
etoricoxib
03
Conditions
painInflammatory Disorders
Beyond the preview
Go deeper on TCTR20240628003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240628003.